Clinical Trial Update: Non-proliferative Diabetic Retinopathy Treated With Runcaciguat [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating runcaciguat for non-proliferative diabetic retinopathy has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Runcaciguat (runcaciguat)

Snippet

Sponsor: Bayer | Conditions: Diabetic Retinopathy | Phase 2 | Status: COMPLETED | Results posted: 2025-04-08